MMJ Stocks

Cannabis Science Inc (OTCMKTS:CBIS) Appoints Mieko Hester-Perez To Lead Autism Treatment Advocacy

Cannabis Science Inc (OTCMKTS:CBIS), better known for its great cannabis-based medicines, announced that it would shift focus to autism and develop drugs that could be helpful for autistic children. To carry out things efficiently, it appointed well-known autism advocate, Mieko Hester-Perez, to its Scientific Advisory Board. Perez will lead the team responsible for developing autism cure.

Road So Far

Mieko Hester-Perez first made it to all the major social media and print platforms when she announced how she was able to heal her son Joey’s autism to a great extent by using medical marijuana. Cannabis Science has already started the proceedings, with Perez to figure out how autism in adults can be treated using cannabinoids.

Many online shreds of evidence show her journey with Joey. Everything started when she took the unconventional path to healing her son Joey (having autism symptoms) with the help of medical cannabis. Joey’s medical reports claim that his mental state has improved significantly after he was exposed to medical marijuana.

Perez has also co-founded Unconventional Foundation for Autism where she shares useful information regarding autism treatments. The government has awarded Perez with Congressional Honors for her community service for differently-enabled children.

The senior management of Cannabis Science believes that Perez’ technical expertise and approach towards autism will help the company serve more and more patients suffering from autism. As no such law allows autism patients to use medical marijuana, it is believed that the presence of Perez on its Scientific Advisory Board will keep the confidence of all the parents of autistic children high.

When asked about this new association, Perez said that she was overwhelmed to receive a call from Cannabis Science. She wanted to spend her time serving children with special needs, and Cannabis Science could be an ideal platform for her to do that.

Cannabis Science will keep its investors abreast of further progress in the autism treatment-related studies.

By Jaime Williams

Jaime is a MBA graduate from UC San Diego and has written for for over 3 months now. She has a particular fondness for the medical marijuana industry but also likes writing on energy, consumer goods, and technology.

Leave a Reply

Your email address will not be published. Required fields are marked *

Can Medical Marijuana Inc (OTCMKTS:MJNA) breakout be on the horizon What California’s Approval Of Recreational Marijuana Means For Cannabis Companies Hemp Inc (OTCMKTS:HEMP) Edging Higher But CEO Fraud Charges Could Cap Momentum Marijuana Edible Go On Sale In Oregon Toronto Pot Dispensaries Continue Operations Amid Raids

Pin It on Pinterest